|
May 07 U.S. Federal Register:
Availability of an
environmental assessment and finding of no significant impact
for a proposed field release of rice genetically engineered to
express lactoferrin, lysozyme, or serum albumin
March 07
USA Rice
Federation files comments with USDA/APHIS, opposes Ventria’s
Kansas rice venture
February 07
Ventria
Bioscience: Availability of an environmental assessment for
field tests of rice genetically engineered to express
lactoferrin, lysozyme, or serum albumin
September 06
Kansas
officials announce agreement with Ventria Bioscience for bioprocessing
facility plant-made pharmaceuticals in Junction
City
December 05
Northwest Missouri State
University and Ventria Bioscience terminate Memorandum of Understanding
June 05
U.S. Federal Register:
Ventria Bioscience -
Availability of environmental assessment and finding of no significant
impact for field tests of genetically engineered rice expressing
lysozyme
May 05
Federal Register:
- Availability of revised
environmental assessment, with consideration for an additional test site
in North Carolina, for field tests of genetically engineered rice
expressing lactoferrin
- Ventria Bioscience -
Availability of revised environmental assessment, with consideration for
an additional test site in North Carolina, for field tTests of
genetically engineered rice expressing lysozyme
November 04
Northwest Missouri
State University and Ventria Bioscience announce collaboration to create
Northwest Missouri Center of Excellence for Plant-Made Pharmaceuticals
June 04
Ventria Bioscience chooses
Iowa for barley test crop
April 04
Genetically altered rice
still headed to market
Ventria likely to miss
opportunity to plant rice
March 04
California Rice Commission
approves Ventria's request to grow the state's first crop genetically
modified to contain a drug
January 04
Ventria Bioscience hopes
to grow commercial rice engineered to make drug compounds
May 03
Aleurone Corporation
announces licensing agreement with Ventria Bioscience for crop genetic
engineering technology
October 02
Ventria Bioscience
supports the Biotechnology Industry Organization (BIO) in developing
standards for plant-made pharmaceuticals and industrials
Ventria Bioscience
announces the launch of ExpressTec(TM), a protein technology
breakthrough for plant made pharmaceuticals
June 00
Tom Urban appointed
Chairman of Ventria Bioscience
|
